Fig. 1From: Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysiscMRI imaging of a 63Â years old patient at a initial diagnosis (T1 weighted imaging with contrast medium), b at relapse (T1 weighted imaging with contrast medium), c also at relapse (diffusion weighted imaging) and d at remission after HD-MTX based retreatment plus focal radiotherapy (T1 weighted imaging with contrast medium)Back to article page